Skip NavigationSkip to Content

Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay

  1. Author:
    Yang, X. Y.
    Chen, E. Y.
    Jiang, H. G.
    Muszynski, K.
    Harris, R. D.
    Giardina, S. L.
    Gromeier, M.
    Mitra, G.
    Soman, G.
  2. Author Address

    Yang, Xiaoyi, Chen, Eying, Jiang, Hengguang, Harris, Raymond D.; Giardina, Steven L.; Mitra, Gautam, Soman, Gopalan] SAIC Frederick Inc, Bioanalyt Dev Lab, Biopharmaceut Dev Program, NCI Frederick, Frederick, MD 21702 USA. [Muszynski, Karen] Natl Canc Inst, Biol Resource Branch, Frederick, MD 21702 USA. [Gromeier, Matthias] Duke Univ, Med Ctr, Div Neurosurg, Dept Surg, Durham, NC 27710 USA.
    1. Year: 2009
    2. Date: Jan
  1. Journal: Journal of Virological Methods
    1. 155
    2. 1
    3. Pages: 44-54
  2. Type of Article: Article
  1. Abstract:

    PVS-RIPO is it recombinant oncolytic poliovirus designed for clinical application to target CD155 expressing malignant gliomas and other malignant diseases. PVS-RIPO does not replicate in healthy neurons and is therefore non-pathogenic in rodent and non-human primate models of poliomyelitis. A tetrazolium salt dye-based cellular assay was developed and qualified to define the cytotoxicity of virus preparations on susceptible cells and to explore the target cell specificity of PVS-RIPO. In this assay, PVS-RIPO inhibited proliferation of U87-MG astrocytoma cells in a dose-dependent manner. However, HEK293 cells were much less susceptible to cell killing by PVS-RIPO. In contrast, the Sabin type 1 live attenuated poliovirus vaccine strain (PV(1)S) was cytotoxic to both HEK293 and U87-MG cells. The correlation between expression of CD155 and cytotoxicity was also explored using six different cell lines. There was little or no expression of CD155 and PVS-RIPO-induced cytotoxicity in Jurkat and Daudi cells. HEK293 was the only cell line tested that showed CD155 expression and resistance to PVS-RIPO cytotoxicity. The results indicate that differential cytotoxicity measured by the colorimetric assay can be used to evaluate the cytotoxicity and cell-type specificity of recombinant strains of poliovirus and to demonstrate lot to lot consistency during the manufacture of viruses intended for clinical use. (c) 2008 Elsevier B.V. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.jviromet.2008.09.020
  2. PMID: 18951922
  3. PMCID: PMC2650828

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel